# Asahi Kasei completes public cash offer for Calliditas, acquires 93.30% of shares

Asahi Kasei Corporation has completed its recommended public cash offer for Calliditas Therapeutics, becoming the owner of 93.30% of all shares in the company.

- Type: Acquisition
- Announced: 2024-09-02
- Where: Sweden
- Status: completed
- Products: pharmaceuticals
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Asahi Kasei](https://endata.com/companies/8888.md) (acquirer)
- [Calliditas Therapeutics](https://endata.com/companies/79837.md) (target)

## Sources

- [news.cision.com](https://news.cision.com/asahi-kasei-corporation/Index/ePaper/[URL%20to%20the%20release]), 2024-09-16: "Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.